Pamrevlumab | m-entrepreneurship.com

Product Name :
Pamrevlumab

Search keywords :
CTGF

drugId :
null

Target Vo:
Connective tissue growth factor

Target Vo Short Name :
CTGF

Moa_Name:
Connective tissue growth factor inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Fibrogen Inc

Active Company_Name :
Beijing Fibrogen Medical Technology Co Ltd

Active Indication_Name:
Pancreatic Neoplasms

In Active Indication_Name:
Muscular Dystrophy, Duchenne

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Tremelimumab In Vivo
Anti-Mouse TNF alpha Antibody (TN3-19.12) Apoptosis
Pyruvate Dehydrogenase E2 Antibody: Pyruvate Dehydrogenase E2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 69 kDa, targeting to Pyruvate Dehydrogenase E2. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts